Background Trimethylamine N‐oxide (TMAO) is a gut microbiota‐dependent metabolite of
dietary choline, L‐carnitine, and phosphatidylcholine‐rich foods. On the basis of …

Background A gut-microbial metabolite, trimethylamine N-oxide (TMAO), has been
associated with coronary atherosclerotic burden. No previous prospective study has …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a compound derived from diet
and metabolism by the gut microbiome, has been associated with several chronic diseases …

Aim: Trimethylamine N-oxide (TMAO) is a gut microbiota-derived metabolite synthesized in
host organisms from specific food constituents, such as choline, carnitine and betaine …

Trimethylamine (TMA) is a gut microbiota-derived metabolite which comes from diets rich of
choline, betaine or l-carnitine and could be further converted to Trimethylamine-N-oxide …

Objectives Recent metabolomic, experimental and clinical studies have demonstrated that
trimethylamine‐N‐oxide (TMAO), a microbiota‐dependent metabolite from dietary …

Rationale: Trimethylamine-N-oxide (TMAO), a gut microbial-dependent metabolite of dietary
choline, phosphatidylcholine (lecithin), and l-carnitine, is elevated in chronic kidney …

ABSTRACT Background Trimethylamine-N-oxide (TMAO) is a gut microbiota–derived
metabolite produced from dietary nutrients. Many studies have discovered that circulating …

Chronic kidney disease (CKD) patients have an increased risk of cardiovascular diseases
(CVDs). The present study aimed to investigate the gut microbiota and blood trimethylamine …

Aim Accumulating evidence has demonstrated that intestinal microbiota‐dependent
trimethylamine N‐oxide (TMAO) is involved in the pathogenesis of various cardiovascular …